ASHLEY STROUD: Open Payments
NPI 1457845240 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 75 payments from 17 companies in 2025. Trend: 2023 $968 · 2024 $1,373 · 2025 $1,646
Food & beverage: $1,546Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $238 |
| AstraZeneca Pharmaceuticals LP | 10 | $217 |
| Lilly USA, LLC | 6 | $182 |
| Regeneron Healthcare Solutions, Inc. | 5 | $176 |
| BioCryst US Sales Co., LLC | 9 | $159 |
| GENZYME CORPORATION | 5 | $156 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $120 |
| CSL Behring | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Ionis Pharmaceuticals, Inc. | 2 | $44 |
Products named: DUPIXENT, ORLADEYO, Rhapsido, TEZSPIRE, NEFFY, AIRSUPRA, AYVAKIT, EBGLYSS.
Industry payments across ID — which companies pay providers there.
